Latest Breaking News On - Janarthanan sathananthan - Page 1 : vimarsana.com

Boston Scientific AGENT Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial

Data from first coronary DCB study in U.S. meet 12-month primary endpoint, demonstrate low adverse event rates with AGENT DCB

United statesRobertw yehJanarthanan sathananthanDrug administrationBoston scientific corporation onBoston scientificHarvard medical schoolCardiovascular research foundationBeth israel deaconess medical centerBoston scientific corporationCoated balloonTranscatheter cardiovascular therapeuticsCardiovascular researchKatz silver family professorHarvard medicalInterventional cardiology therapies

TCT: Boston Scientific s drug-coated coronary balloon outperforms typical uncoated angioplasty

TCT: Boston Scientific s drug-coated coronary balloon outperforms typical uncoated angioplasty
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesJanarthanan sathananthanRobert yehBoston scientificBeth israel deaconess medical centerKatz silver family professorHarvard medical

Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial

Boston Scientific AGENT™ Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJanarthanan sathananthanAngela mineoColl cardiolRobertw yehRobert yehLauren tenglerBoston scientific corporationExchange commissionDrug administrationBeth israel deaconess medical centerCardiovascular research foundationSecurities exchangePrnewswire boston scientific corporationBoston scientificScientific corporation

Boston Scientific Gets Positive Results for Heart-Failure Device

By Sabela Ojea Boston Scientific said its clinical trial to treat coronary in-stent restenosis with its investigational device met its primary endpoint,.

United statesJanarthanan sathananthanSabela ojeaBoston scientificAgent drug coated balloonArticle normalMedical equipment suppliesHealthcare life sciencesMedical devices apparatusNew products servicesResearch developmentCorporate industrial newsProducts servicesNew product service testingCardiovascular conditionsPolitical general news

Boston Scientific AGENTtm Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial

Boston Scientific AGENTtm Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesColl cardiolJanarthanan sathananthanRobertw yehLauren tenglerAngela mineoRobert yehDrug administrationBoston scientificExchange commissionBeth israel deaconess medical centerSecurities exchangeCardiovascular research foundationPrnewswire boston scientific corporationBoston scientific corporationDrug coated balloon demonstrates superiority